Testosterone is the primary male sex hormone — but its role in the body extends far beyond sexual function. Testosterone influences muscle mass, bone density, energy metabolism, mood, cognitive function, and metabolic health. When levels fall below what the body needs to function optimally, the effects are widespread and often gradual enough that many men don't recognize them as a medical issue.
Low testosterone — clinically referred to as hypogonadism or testosterone deficiency syndrome — is more common than most men realize. Estimates suggest it affects between 10 and 40% of men, with prevalence increasing significantly with age. Yet many cases go undiagnosed because the symptoms are nonspecific, overlap with other conditions, and are frequently attributed simply to "getting older."
This guide explains what low testosterone is, how it manifests clinically, why it matters for metabolic health, and how individualized clinical evaluation guides treatment decisions.
Clinical note: Low testosterone is diagnosed through laboratory testing in combination with clinical symptoms — not by symptoms alone. Individual evaluation by a licensed provider is required for diagnosis and treatment planning. This article is for educational purposes only.
Testosterone is an androgen hormone produced primarily in the testes under the direction of the hypothalamic-pituitary-gonadal (HPG) axis. The hypothalamus releases gonadotropin-releasing hormone (GnRH), which signals the pituitary to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH then signals the Leydig cells in the testes to produce testosterone.
Testosterone circulates in the blood in two primary forms: bound to sex hormone-binding globulin (SHBG) or albumin, and free (unbound). Free testosterone is the biologically active fraction — able to enter cells and exert its effects. Both total and free testosterone levels are clinically relevant.
Testosterone's physiological roles include:
Testosterone levels in men peak in the late teens to early twenties and then decline gradually — at an average rate of approximately 1-2% per year — beginning in the late twenties or early thirties. This age-related decline, sometimes called andropause or late-onset hypogonadism, is a normal physiological process.
However, two important points deserve emphasis. First, the rate of decline varies considerably between individuals — some men maintain robust testosterone levels into their 60s and 70s, while others experience more rapid decline beginning in their 30s or 40s. Second, symptomatic testosterone deficiency is not simply an inevitable consequence of aging — it is a clinical condition that can occur at any age and that has identifiable causes and treatment options.
The average total testosterone level in American men has also declined over the past several decades — a population-level trend that researchers have attributed to rising rates of obesity, sedentary behavior, endocrine-disrupting environmental exposures, and other factors. This means that age-adjusted comparisons to historical reference ranges may underestimate true testosterone deficiency in contemporary men.
The symptoms of testosterone deficiency are diverse and often gradual in onset. Many men have multiple symptoms for years before seeking evaluation — if they seek it at all. Recognizing the clinical picture is the first step toward appropriate assessment.
Decreased sexual desire is one of the most consistently reported symptoms of testosterone deficiency. It may manifest as reduced interest in sexual activity, decreased frequency of sexual thoughts, or a general blunting of sexual motivation that the patient recognizes as different from their baseline.
Testosterone contributes to the sensitivity of erectile tissue and the maintenance of smooth muscle in the corpus cavernosum. Low testosterone is associated with erectile dysfunction — though vascular and metabolic factors often coexist. See our detailed article on causes of erectile dysfunction.
Persistent fatigue, reduced stamina, and a general sense of low energy are among the most common and least specific symptoms of testosterone deficiency. Many men describe it as feeling like they are running at a reduced capacity — less able to sustain effort, physical or cognitive.
Testosterone is anabolic — it promotes muscle protein synthesis. In testosterone deficiency, muscle mass and strength decline even in men who maintain their exercise habits. This loss of lean mass is often accompanied by increased difficulty building or maintaining muscle despite training.
Low testosterone is associated with increased fat accumulation — particularly visceral fat. Visceral fat produces aromatase, which converts testosterone to estrogen, further lowering testosterone levels. This creates a reinforcing cycle that drives continued metabolic dysfunction.
Testosterone has direct effects on mood, motivation, and emotional regulation through its actions in the brain. Men with low testosterone frequently report depressed mood, increased irritability, reduced motivation, and a general loss of drive that does not respond to conventional approaches.
Difficulty concentrating, reduced mental clarity, and memory changes are reported by many men with testosterone deficiency. These cognitive symptoms are often subtle but can significantly affect work performance and quality of life.
Testosterone plays an important role in bone mineral density maintenance. Long-standing testosterone deficiency increases the risk of osteoporosis and fracture — a consequence that is frequently underappreciated in the clinical discussion of men's health.
Important: None of these symptoms are specific to testosterone deficiency. They can result from thyroid dysfunction, sleep disorders, depression, metabolic syndrome, and many other conditions. Symptom-based diagnosis without laboratory confirmation is not clinically appropriate. Evaluation by a licensed provider is necessary.
One of the most clinically important aspects of testosterone deficiency is its bidirectional relationship with metabolic health. This is not simply a correlation — the mechanisms are well understood and directly relevant to clinical care.
Adipose tissue — particularly visceral fat — expresses aromatase, the enzyme responsible for converting androgens (including testosterone) to estrogens. In men with significant visceral adiposity, aromatase activity is elevated, continuously converting testosterone to estradiol. The resulting hormonal imbalance — lower testosterone, higher estrogen — suppresses the HPG axis and reduces testicular testosterone production.
Additionally, adipose tissue produces inflammatory cytokines that directly impair Leydig cell function and reduce testosterone production. Insulin resistance — closely associated with visceral adiposity — also impairs the HPG axis at multiple levels.
The relationship runs in both directions. Testosterone deficiency promotes fat accumulation, reduces insulin sensitivity, decreases muscle mass, and impairs mitochondrial function — all of which worsen metabolic health. Men with low testosterone have significantly higher rates of metabolic syndrome, type 2 diabetes, and cardiovascular disease.
This bidirectional relationship is why clinician-guided metabolic health programs — including those addressing weight management — are relevant to testosterone health. GLP-1 medical weight loss programs that reduce visceral adiposity can meaningfully improve testosterone levels through the mechanisms described above, independent of any direct hormonal intervention.
The relationship between low testosterone and erectile dysfunction is real but nuanced. Testosterone deficiency reduces libido and can contribute to erectile difficulty — but for most men, ED is not primarily a hormonal condition. Vascular factors — impaired blood flow due to cardiovascular disease, hypertension, and metabolic dysfunction — are the most common primary cause of ED.
In clinical practice, low testosterone and vascular ED frequently coexist, and addressing both is typically more effective than addressing either in isolation. A comprehensive clinical evaluation assesses both hormonal and vascular contributors and develops an individualized treatment plan accordingly.
Diagnosis of testosterone deficiency requires two elements: clinical symptoms consistent with hypogonadism, and confirmed low serum testosterone on laboratory testing. Symptoms alone are not sufficient — nor is a low testosterone level in the absence of clinical symptoms.
The standard initial test is a morning total testosterone measurement (testosterone is highest in the morning and declines throughout the day). If results are borderline or symptoms are inconsistent with total testosterone levels, additional testing may include:
Interpretation requires clinical context. A testosterone level that is "within the reference range" may still be suboptimal for a particular patient. Equally, a low testosterone level may not require treatment if symptoms are absent. Clinical judgment — not laboratory values alone — guides decisions.
Testosterone replacement therapy (TRT) is the most direct treatment for confirmed hypogonadism. It involves restoring testosterone to physiologically appropriate levels through various delivery methods — intramuscular or subcutaneous injections, transdermal gels or patches, implantable pellets, or oral preparations.
TRT has a well-established evidence base for improving the symptoms of testosterone deficiency — including libido, energy, mood, body composition, and bone density — in men who are appropriate candidates.
Candidacy for TRT requires individual clinical evaluation. It is contraindicated in men with active prostate cancer, severe untreated sleep apnea, polycythemia vera, and in men who desire to preserve fertility (TRT suppresses endogenous testosterone production and sperm production).
SEVEN is developing a testosterone replacement program as part of our hormone optimization platform — coming soon as part of our expanding metabolic health services. If you are interested in being notified when TRT becomes available, join our early access list.
Low testosterone does not exist in isolation. It is deeply embedded in the broader landscape of men's metabolic health — connected to weight, metabolic function, cardiovascular health, sexual health, and psychological wellbeing through multiple overlapping mechanisms.
Effective clinical care for testosterone deficiency therefore requires more than a prescription. It requires an individualized evaluation that considers the full metabolic and hormonal picture, a treatment plan that addresses contributing factors alongside the hormonal deficit, and ongoing clinical support to monitor response and adjust as needed.
This integrated approach — treating hormone health within the context of comprehensive metabolic health — is central to how SEVEN designs its clinical programs. Whether the entry point is weight loss, metabolic optimization, ED treatment, longevity medicine, or hormone health, the underlying goal is the same: personalized clinical care that addresses the full picture of a patient's health, not a single symptom or biomarker.
SEVEN is building a clinician-guided platform for metabolic health, weight loss, sexual health, and hormone optimization. Join early access to be notified when programs become available.
Join Early Access →